Evidence map›Paper›PMID 34895794›Full record

ArticleSchizophrenia research2023

Race and self-reported paranoia: Increased item endorsement on subscales of the SPQ.

J Wolny, Alexandra B Moussa-Tooks, Allen J Bailey, Brian F O'Donnell, William P Hetrick

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

J WolnyDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States of America.
Alexandra B Moussa-TooksDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States of America; Program in Neuroscience, Indiana University, Bloomington, IN, United States of America; Department of Psychiatry and Behavioral Sciences, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Allen J BaileyDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States of America.
Brian F O'DonnellDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States of America; Program in Neuroscience, Indiana University, Bloomington, IN, United States of America; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, United States of America.
William P HetrickDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States of America; Program in Neuroscience, Indiana University, Bloomington, IN, United States of America; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, United States of America. Electronic address: whetrick@indiana.edu.
Indiana University Bloomington · USIndiana University – Purdue University Indianapolis · USVanderbilt University · US

Funding

Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Cerebellar timing dysfunction in schizophreniaR01MH074983 · NIMH · TRUSTEES OF INDIANA UNIVERSITY · PI HETRICK, WILLIAM P · 2006 to 2016
$3.6M
Training in Clinical Translational Science: Maximizing the Public Health ImpactT32MH103213 · NIMH · TRUSTEES OF INDIANA UNIVERSITY · PI WILLIAM P HETRICK · 2015 to 2026
$3.4M
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITYT32DA024628 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI Andrea Grace Hohmann, Kenneth Mackie · 2008 to 2026
$3.1M
Indiana Clinical and Translational Sciences InstituteTL1TR001107 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$2.0M
Cerebellar Dysfunction in AutismR21MH118617 · NIMH · TRUSTEES OF INDIANA UNIVERSITY · PI HETRICK, WILLIAM P · 2019 to 2020
$433k
Neural Oscillations in Schizophrenia and a Rat ModelR21MH091774 · NIMH · TRUSTEES OF INDIANA UNIVERSITY · PI O'DONNELL, BRIAN FRANCIS · 2010 to 2011
$421k
NCATS NIH HHS TL1 TR001107NCATS NIH HHS UL1 TR001108NIDA NIH HHS T32 DA024628NIMH NIH HHS R01 MH074983NIMH NIH HHS R21 MH091774NIMH NIH HHS R21 MH118617NIMH NIH HHS T32 MH103213
6 · The paper itself

Abstract

There is a dearth of research examining how individual-level and systemic racism may lead to elevated diagnostic and symptom rates of paranoia in Black Americans. The present study employed item response theory methods to investigate item- and subscale-level functioning in the Schizotypal Personality Questionnaire (SPQ) in 388 Black and 450 White participants across the schizophrenia-spectrum (i.e., non-psychiatric controls, individuals with schizophrenia, schizoaffective disorder, or schizotypal personality disorder). It was predicted that (1) Black participants would score significantly higher than Whites on the Suspiciousness and Paranoid Ideation subscale of the SPQ, while controlling for total SPQ severity and relevant demographics and (2) Black participants would endorse these subscale items at a lower latent severity level (i.e., total SPQ score) compared to Whites. Generalized linear modeling showed that Black participants endorsed higher scores on subscales sampling paranoia (e.g., Suspiciousness and Paranoid Ideation), while White participants endorsed higher rates within disorganized/positive symptomatology subscales (e.g., Odd or Eccentric Behavior). IRT analyses showed that Black individuals also endorse items within the Suspiciousness and Paranoid Ideation subscale at lower latent severity levels, leading to inflated subscale scores when compared to their White counterparts. Results indicate prominent race effects on self-reported paranoia as assessed by the SPQ. This study provides foundational data to parse what could be normative endorsements of paranoia versus indicators of clinical risk in Black Americans. Implications and recommendations for paranoia research and assessment are discussed.

Indexed as

Psychotic DisordersSchizotypal Personality DisorderHumansParanoid DisordersPersonalitySelf ReportSurveys and QuestionnairesBlack/African AmericanParanoiaRacial disparitiesSchizophrenia spectrumSchizotypal Personality QuestionnaireStigma

Identifiers

PMID34895794
PMCPMC9177896
OpenAlexW4200486421

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.